ADC Therapeutics SA Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment
ADC Therapeutics SA (ADCT) reported Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment of -$235.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Income Statement › Other Income
us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1 · last filed 2026-03-10
- ADC Therapeutics SA defined benefit plan, net periodic benefit cost (credit), gain (loss) due to settlement and curtailment for fiscal 2025 was -$235.00K.
- ADC Therapeutics SA defined benefit plan, net periodic benefit cost (credit), gain (loss) due to settlement and curtailment for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- ADC Therapeutics SA defined benefit plan, net periodic benefit cost (credit), gain (loss) due to settlement and curtailment for fiscal 2023 was $79.00K.
- ADC Therapeutics SA defined benefit plan, net periodic benefit cost (credit), gain (loss) due to settlement and curtailment for fiscal 2022 was $0.00.
| Period end | Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment 12 month |
|---|---|
| 2025-12-31 | -$235.00K 10-K · filed 2026-03-10 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-10 |
| 2023-12-31 | $79.00K 10-K · filed 2025-03-27 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |